← FDA DRUG APPROVALS

FDA BLA · BLA761486

TRUTAKNA

atacicept

Sponsor: VERA THERAPEUTICS INC.

APPLICATION
BLA761486
TYPE
BLA
ORIGINAL APPROVAL
2026-07-07
LATEST ACTION
2026-07-07
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TRUTAKNAPrescription
ATACICEPT-VYMJ 150MG/ML · INJECTABLE · SUBCUTANEOUS

Approval history

2026-07-07Type 1 - New Molecular Entity · Original · priorityLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →